157 related articles for article (PubMed ID: 31957836)
21. LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis.
Wang W; Luo P; Guo W; Shi Y; Xu D; Zheng H; Jia L
Biochem Biophys Res Commun; 2018 Sep; 503(3):1927-1933. PubMed ID: 30072099
[TBL] [Abstract][Full Text] [Related]
22. Repression of lncRNA-SVUGP2 mediated by EZH2 contributes to the development of non-small cell lung cancer via brisking Wnt/β-catenin signal.
Wei S; Liu J; Li X; Liu X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3400-3409. PubMed ID: 31401873
[TBL] [Abstract][Full Text] [Related]
23. LncDBH-AS1 knockdown enhances proliferation of non-small cell lung cancer cells by activating the Wnt signaling pathway via the miR-155/AXIN1 axis.
Shi XY; Tao XF; Wang GW; He JF; Wu LF; Sun YZ; Sun XJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):139-144. PubMed ID: 33506901
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
25. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
26. LncRNA UCA1 inhibits proliferation and promotes apoptosis of cervical cancer cells by regulating β-catenin/TCF-4.
Duan DM; Zhang L; Hua F
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5963-5969. PubMed ID: 32572909
[TBL] [Abstract][Full Text] [Related]
27. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
28. LncRNA SNHG20 contributes to cell proliferation and invasion by upregulating ZFX expression sponging miR-495-3p in gastric cancer.
Cui N; Liu J; Xia H; Xu D
J Cell Biochem; 2019 Mar; 120(3):3114-3123. PubMed ID: 30520073
[TBL] [Abstract][Full Text] [Related]
29. Low expression of LncRNA AFAP1-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells through inhibiting wnt signaling pathway.
Sun Y; Fan L; Li Y
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(12):176-180. PubMed ID: 38063100
[TBL] [Abstract][Full Text] [Related]
30. Highly expressed lncRNA LOC730101 promotes lung cancer cell growth through Wnt canonical pathway.
Liu L; Zhang Y; Cao W
Biochem Biophys Res Commun; 2017 Nov; 493(2):992-997. PubMed ID: 28943432
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of LINC00261 inhibits non-small cell lung cancer cells progression by interacting with miR-522-3p and suppressing Wnt signaling.
Shi J; Ma H; Wang H; Zhu W; Jiang S; Dou R; Yan B
J Cell Biochem; 2019 Oct; 120(10):18378-18387. PubMed ID: 31190356
[TBL] [Abstract][Full Text] [Related]
32. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
33. LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway.
Wang ZX; Xu ZN; Sun HB; Wang Y; Han ZF; Yu Y; Han XL; Yin YY; Xu L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):222-229. PubMed ID: 31957835
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus x protein accelerated the proliferation of hepatocellular carcinoma cell through lncRNA SNHG20/PTEN pathway.
Tu W; Yang Y; Song Y; Zhu W
J Biochem; 2019 May; 165(5):423-431. PubMed ID: 30690477
[TBL] [Abstract][Full Text] [Related]
35. AOC4P suppresses viability and invasion and induces apoptosis in NSCLC cells by inhibiting the Wnt/β-catenin pathway.
Li F; Rong T; Cao G; Zhai C; Li Q; Gong R; Li G
Chem Biol Interact; 2020 Jul; 325():109110. PubMed ID: 32325081
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression.
Chen Z; Chen X; Chen P; Yu S; Nie F; Lu B; Zhang T; Zhou Y; Chen Q; Wei C; Wang W; Wang Z
Cell Death Dis; 2017 Oct; 8(10):e3092. PubMed ID: 28981099
[TBL] [Abstract][Full Text] [Related]
37. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
40. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
